| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10534-017-0010-5 |
| P698 | PubMed publication ID | 28303360 |
| P50 | author | Ekaterina A Litus | Q89552669 |
| P2093 | author name string | Eugene A Permyakov | |
| Sergei E Permyakov | |||
| Ekaterina L Nemashkalova | |||
| P2860 | cites work | Allosteric modulation of zinc speciation by fatty acids | Q38111113 |
| Binding of transition metal ions to albumin: sites, affinities and rates | Q38118028 | ||
| A clinical update of using albumin as a drug vehicle - a commentary | Q38196660 | ||
| Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: Rationale and treatment approach of the AMBAR (Alzheimer Management By Albumin Replacement) study | Q38229421 | ||
| Multifunctional Effect of Human Serum Albumin Reduces Alzheimer's Disease Related Pathologies in the 3xTg Mouse Model | Q38810704 | ||
| Oleic acid is a key cytotoxic component of HAMLET-like complexes | Q39342445 | ||
| A novel method for preparation of HAMLET-like protein complexes | Q39539749 | ||
| A molecular mechanism for modulating plasma Zn speciation by fatty acids | Q41470913 | ||
| Stoichiometry and affinity of the human serum albumin-Alzheimer's Aβ peptide interactions | Q41474461 | ||
| Probing conformational changes of human serum albumin due to unsaturated fatty acid binding by chemical cross-linking and mass spectrometry | Q41985486 | ||
| Human serum albumin can regulate amyloid-β peptide fiber growth in the brain interstitium: implications for Alzheimer disease | Q42322241 | ||
| Fatty acids binding to human serum albumin: Changes of reactivity and glycation level of Cysteine-34 free thiol group with methylglyoxal. | Q42703393 | ||
| Free fatty acid determination in plasma by GC-MS after conversion to Weinreb amides | Q44918099 | ||
| Use of the phase diagram method to analyze the protein unfolding-refolding reactions: fishing out the "invisible" intermediates | Q44978160 | ||
| Combined fluorescence and electrochemical investigation on the binding interaction between organic acid and human serum albumin. | Q45919028 | ||
| Albumin's role in steroid hormone action and the origins of vertebrates: is albumin an essential protein? | Q45939075 | ||
| Who is Mr. HAMLET? Interaction of human alpha-lactalbumin with monomeric oleic acid | Q46112145 | ||
| Binding of calcium to serum albumin. III. Influence of ionic strength and ionic medium | Q47764836 | ||
| Effects on transthyretin in plasma and cerebrospinal fluid by DHA-rich n - 3 fatty acid supplementation in patients with Alzheimer's disease: the OmegAD study | Q48093686 | ||
| CSF and serum concentrations of albumin and IgG in Alzheimer's disease | Q48233637 | ||
| A bioinorganic view of Alzheimer's disease: when misplaced metal ions (re)direct the electrons to the wrong target | Q48280428 | ||
| Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis | Q48682040 | ||
| Serum levels of albumin-amyloid beta complexes are decreased in Alzheimer's disease | Q49053063 | ||
| Improved two-dimensional gel electrophoresis representation of serum proteins by using ProtoClear. | Q50518577 | ||
| Correspondence of fatty acid and drug binding sites on human serum albumin: a two-dimensional nuclear magnetic resonance study. | Q51834942 | ||
| Equilibrium dialysis of metal-serum albumin. I. Successive stability constants of Zn(II)-serum albumin and the Zn(2+)-induced cross-linking self-association. | Q52374484 | ||
| Oleic acid and linoleic acid from Tenebrio molitor larvae inhibit BACE1 activity in vitro: molecular docking studies. | Q52766426 | ||
| Hydroxyoctadecadienoic acid and oxidatively modified peroxiredoxins in the blood of Alzheimer's disease patients and their potential as biomarkers. | Q53288446 | ||
| Plasma fatty acid lipidomics in amnestic mild cognitive impairment and Alzheimer's disease. | Q53339637 | ||
| Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy. | Q53385413 | ||
| Selective removal of albumin from plasma by affinity chromatography. | Q53762860 | ||
| European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: Electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, p | Q55868024 | ||
| Human serum albumin inhibits Abeta fibrillization through a "monomer-competitor" mechanism | Q24646788 | ||
| Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin | Q27627815 | ||
| Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids | Q27636833 | ||
| Structural and immunologic characterization of bovine, horse, and rabbit serum albumins | Q27679534 | ||
| How to measure and predict the molar absorption coefficient of a protein | Q27860551 | ||
| A beta oligomers - a decade of discovery | Q29615152 | ||
| Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics | Q30244736 | ||
| Circulatory zinc transport is controlled by distinct interdomain sites on mammalian albumins | Q30252235 | ||
| Cell and molecular biology of transthyretin and thyroid hormones. | Q30360169 | ||
| Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB. | Q30422007 | ||
| Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs | Q30637358 | ||
| Mapping the interactions between the Alzheimer's Aβ-peptide and human serum albumin beyond domain resolution | Q30671407 | ||
| Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's disease | Q33793583 | ||
| Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment | Q33934660 | ||
| Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: a 10-y prospective follow-up study | Q34628274 | ||
| National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease | Q34635272 | ||
| Current and future treatments for Alzheimer's disease | Q34646921 | ||
| Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies | Q34664133 | ||
| Comprehensive profiling of plasma fatty acid concentrations in young healthy Canadian adults | Q35078129 | ||
| Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease | Q35885375 | ||
| Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study | Q36081622 | ||
| Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease | Q36132033 | ||
| Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans | Q36306234 | ||
| Extrinsic fluorescent dyes as tools for protein characterization | Q36738230 | ||
| The redox chemistry of the Alzheimer's disease amyloid beta peptide. | Q36791163 | ||
| Albumin as fatty acid transporter | Q37595250 | ||
| Lessons from the crystallographic analysis of small molecule binding to human serum albumin | Q37595256 | ||
| Amyloid-targeted therapeutics in Alzheimer's disease: use of human albumin in plasma exchange as a novel approach for Abeta mobilization. | Q37601322 | ||
| Alzheimer's disease and the amyloid-beta peptide | Q37671455 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 341-353 | |
| P577 | publication date | 2017-03-16 | |
| P1433 | published in | BioMetals | Q15767134 |
| P1476 | title | Modulation of linoleic acid-binding properties of human serum albumin by divalent metal cations | |
| P478 | volume | 30 |
| Q64088923 | Crosstalk between zinc and free fatty acids in plasma | cites work | P2860 |
Search more.